Sign in to follow
Search Results

0 results for 'Juno Therapeutics'

You can use to get even better search results
January 14, 2020 | Law.com

Skilled in the Art: Neal Katyal Asks SCOTUS for the Big Kahuna + Lawyers React to Section 101 Silence + Another Multimillion-Dollar Verdict for Irell

A few outtakes from the trademark damages arguments in Romag v. Fossil at the U.S. Supreme Court.
5 minute read
December 20, 2019 | Litigation Daily

And the LOTW Runners Up...

Honorable mention goes to lawyers from Irell & Manella; Gibson Dunn; Quinn Emanuel; Porter Wright; Pepper Hamilton; Jenner & Block; Erise IP and Kirkland & Ellis.
4 minute read
December 17, 2019 | Litigation Daily

Irell's Morgan Chu Breaks Down a $752 Million Verdict Over Cancer Therapy

The IP litigator led a team of Irell & Manella and Jones Day attorneys in an eight-day trial on behalf of Juno Therapeutics and Memorial Sloan-Kettering Cancer Center. The companies had accused Kite Pharma of infringing a patent on ground-breaking CAR T immunotherapy.
7 minute read
December 17, 2019 | The Recorder

Morgan Chu Breaks Down a $752 Million Verdict Over Cancer Therapy

The IP litigator led a team of Irell & Manella and Jones Day attorneys in an eight-day trial on behalf of Juno Therapeutics and Memorial Sloan-Kettering Cancer Center. The companies had accused Kite Pharma of infringing a patent on ground-breaking CAR T immunotherapy.
7 minute read
December 17, 2019 | Law.com

Skilled in the Art: Breaking Down a $752M Verdict with Morgan Chu + The Arthrex En Banc Petitions Are In + Is Supreme Court Clearing the Decks for a Section 101 Landing?

A conversation with Irell & Manella partner Morgan Chu about the $752 million jury verdict he just helped engineer last week.
14 minute read
February 25, 2019 |

Revenue, Profits on the Rise for Transatlantic Hogan Lovells

With revenue up but head count slightly down, CEO Steve Immelt said the firm had a strong year across key regions.
5 minute read
February 25, 2019 | New York Law Journal

Revenue, Profits on the Rise for Transatlantic Hogan Lovells

The firm is looking to add corporate capabilities in New York, Houston, Boston and London. It will move into new spaces in New York this summer.
5 minute read
February 25, 2019 | The American Lawyer

Revenue, Profits on the Rise for Transatlantic Hogan Lovells

With revenue up but head count slightly down, CEO Steve Immelt said the firm had a strong year across key regions.
5 minute read
February 13, 2019 | The American Lawyer

Proskauer Nears $1B Revenue Mark as It Posts New Profit Highs

The firm saw gross revenue grow by 9.8 percent, while profits per equity partner jumped 12.4 percent.
5 minute read
January 22, 2018 | The American Lawyer

In Latest Lateral Payoff, Paul Weiss Grabs Role in Bioverativ Sale

Scott Barshay left Cravath, Swaine & Moore in 2016. At Paul Weiss, he has been compiling a growing list of clients with ties to his old firm. His most recent deal is the nearly $12 billion sale of drugmaker Bioverativ.
5 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now